Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age9-17
SponsorSyracuse University

About this trial

The goal of this randomized-controlled trial is to compare distributed treatment schedules and intensive treatment schedules in 84 school-age children with residual speech sound disorders. The main question it aims to answer is:

* How does intensive and distributed treatment affect speech sound learning in residual speech sound disorder?

Some participants will be treated with a traditional Distributed schedule of 2 sessions per weeks for 8 weeks (16 hours total), whereas others will be treated with an Intensive schedule and will complete 16 hours of treatment in 4 weeks.

Eligibility criteria

Qualifiers

Must speak American English as a dominant language.

Must have began learning English by at least the age of 3 years.

Must be between 9;0 to 17;11 years of age.

Must have reported difficulty with /ɹ/ and/or /s/ production

Disqualifiers

Must have no known history of autism spectrum disorder, Down Syndrome, cerebral palsy, intellectual disability, permanent hearing loss, or brain injury.

Must not have current cleft palate or voice disorder.

Trial design

Treatments tested in this trial

  • Speech Motor Chaining

Treatment groups

84 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Syracuse University

Lead sponsor

National Institutes of Health (NIH)

Collaborator

State University of New York - Upstate Medical University

Collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator